Urology Coding and Reimbursement Podcast

UCR 280: Testosterone Pellet Denials, Secondary Payer Prior Auths, and Urology Risk Assessments

Episode 280

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 28:42

March 13, 2026 

In this episode, Scott, Mark, and Dr. Ray Painter tackle three emerging reimbursement challenges affecting urology practices: widespread denials for testosterone pellet (Testopel®) therapy, the growing trend of secondary payers requiring prior authorization for high-cost drugs, and whether urology questionnaires qualify as billable health risk assessments.


 PRS Coding and Reimbursement Hub

Access the Hub


Botox LCD Alert

Download the Alert


Free In-Office Prostate Biopsy Calculator (Suppoted by UC-Care)

Download Now


PRS Coding Courses

For Urologist

For APPs

For Coders, Billers, and Admins

 


Join the Urology Pharma and Tech Pioneer Group

Empowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.

         https://www.prsnetwork.com/joinuptp



Click Here to Start Your Free Trial of AUACodingToday.com


   The Thriving Urology Practice Facebook group.

The Thriving Urology Practice Facebook Group link to join:

https://www.facebook.com/groups/ThrivingPractice/